Investment Pitches

Pitch Summary:
Halyk Bank shares were first acquired for the Fund in July 2023, almost two years ago. And yet, it was not written extensively in a Letter. Halyk is the largest Bank in Kazakhstan (depending on the measure, 20% to 40% market share). Therefore, for good and bad, Kazakhstan's economy is inherently important to the success of this investment. I am no expert, and had not even been interested in Central Asian economies before hearing about it. In a number of credit measures (USD sovereign yield, credit ratings, debt to GDP), and recent historical GDP growth, it ranks better than Brazil or Mexico. Even in terms of GDP per capita, it is situated between these two Latin American "peers"; it can largely be considered a middle income country. I doubt that a decision of investing in a market leader in these (not so) comparable countries would be second guessed. Inflation in the past few years has been high (8% to 10%), but not rampant or out of control; importantly, real rates have been positive. One can expect some, hopefully well behaved, FX depreciation through time - again, not dissimilar to other emerging markets. How well does Halyk operate in this environment? Benchmarking against other EM country leaders (banks with more than 15% market share; there are not many of them around), it certainly stands out. In fact, Halyk Bank is the best performer in all measures shown in the image below. The numbers are impressive enough that one can suspect if they can be sustained, or if it is temporarily over earning. For more than 10 years their ROEs stood above 20% - and that included a collapse in their currency by way of de-pegging, years of subdued oil price (Kazakhstan is highly dependent on oil and gas exports), a pandemic, an unsuccessful coup, and so on. Importantly, in theory the bank should be able to increase its leverage in order to keep high ROEs. For 2025, their guidance is 30% - 33% ROE. Historically, it has been able to beat its guidances. Given that Kazakhstan is considered a frontier market, and it is geographically located between Russia and China, it usually trades at a discount, with total market cap around book value, even presenting those high returns year after year. For the math wizards, a complex (cough) question: taking trading costs aside, what would be the prospective return of a stock that trades at book value, pays 50%(ish) of its profits in dividend which can be quickly redeployed at 1x price to book value, and keeps delivering 30% ROEs? That is right: 30% - in tengge terms, at least; probably a few percentage points less in USD because of potential FX depreciation. In fact, from that first acquisition for the Fund in July 2023 up to the end of April, we have received more than 30% of the cost basis in dividends (which were mostly redeployed in more Halyk shares), and the stock appreciated more than 50%. All the while, its valuation barely budged. As most Central Asian economies, Kazakhstan has a shallow banking penetration: according to the IMF, bank deposits to GDP are around 30%. That compares to 45% in Mexico, 65% in Russia, 90% in Turkey or more than 100% in Brazil. So room to grow should not be a concern for at least a decade. In any case, if the economy does not provide for profitable loan growth, the bank could increase its payout, which at the moment is around 50% of its profits (that equates to more than 15% dividend yield at current share prices). As long as valuation levels remain unchanged, redeploying the proceeds into more shares may be an attractive alternative. It reminds me of when Warren Buffett bought IBM shares in November 2011. His rationale was that 1) valuation was cheap to fair and 2) the company was using the bulk of its cash flow to buy back shares. His description of how he wanted IBM's stock price to trade throughout the following years got imprinted in my mind: "I want it to languish". That is my way of thinking about Halyk shares - as long as it keeps delivering 30% or so ROEs.

BSD Analysis:
The manager presents a compelling bull case for Halyk Bank, Kazakhstan's dominant banking franchise with 20-40% market share. The investment thesis centers on exceptional profitability metrics, with ROEs consistently above 20% for over a decade and 2025 guidance of 30-33% ROE. The bank trades at approximately 1x book value despite these superior returns, creating an attractive valuation disconnect. Kazakhstan's shallow banking penetration (30% deposits-to-GDP vs 100%+ in Brazil) provides significant runway for organic growth over the next decade. The manager emphasizes the compounding opportunity through high dividend yields (15%+ at current prices) with 50% payout ratios that can be reinvested at attractive valuations. The 30% prospective returns in local currency terms, adjusted for potential FX depreciation, represent compelling risk-adjusted returns for a market-leading franchise in a stable emerging market economy.

Pitch Summary:
River Global’s “B” shares (RVRB) provide direct economic exposure to the company’s 30% stake in Parmenion Capital Partners, a fast-growing UK wealth-tech platform that combines investment administration with discretionary fund management for over 1,500 adviser firms. The stub was created in March 2025 to isolate this asset from River Global’s troubled operating businesses, making its value transparent and investable. Parmenion’s £12.6 bn AUA, £48.6 m revenue, and £17.9 m EBITDA (FY 2023) highlight strong scalability and high client stickiness due to its proprietary tech and adviser-centric platform model. At today’s price, RVRB implies only ~8× EV/EBITDA and ~1.2 % EV/AUA for Parmenion, far below listed UK platform peers (~13–14× and ~2 % EV/AUA) and prior independent valuations (£75–£90 m for the 30 % stake). In 2022, owners explored a £300–£400 m sale for Parmenion, and both operating growth and market conditions have improved since. Harwood Capital’s Christopher Mills—RVRB’s largest shareholder and NED—has been buying stock, underlining insider conviction in the discount. Preservation Capital Partners, which owns 70 %, is a 2019-vintage PE fund nearing its 2026–2028 exit window; the public RVRB quote adds mark-to-market pressure that could accelerate a sale or IPO. The setup offers asymmetric upside: even if valued at peer averages, RVRB could rise 60–100 %, while downside is limited by transparent audited NAV and peer comparables. Key catalysts include stronger Parmenion AUA growth, further insider purchases, and a strategic or secondary PE exit.

BSD Analysis:
The RVRB stub isolates a high-quality, cash-generative platform from a messy holdco, creating a rare pure-play entry into a private fintech asset at a fraction of peer value. The market misprices complexity and minority-ownership optics rather than fundamentals. With PCP likely to monetize Parmenion within 1–3 years, Harwood’s insider buying, and strong KPIs, a convergence toward peer EV/AUA and EV/EBITDA is probable. Risks include shareholder-agreement limits, slower platform inflows, or a prolonged PE hold, but liquidity, valuation transparency, and alignment all support a favorable risk-reward.

Pitch Summary:
Bird Construction is positioned as a high-conviction investment due to its strong operational performance amidst challenging market conditions. The company has successfully navigated tariff-related market sentiment, leading to an opportunity to acquire shares at a favorable valuation. With rising margins and a record-level backlog, Bird Construction demonstrates robust business fundamentals and effective management.

BSD Analysis:
Bird Construction's strategic focus on maintaining a strong backlog and improving margins indicates a resilient business model capable of weathering external economic pressures. The construction sector often faces cyclical challenges, but Bird's ability to capitalize on tariff fears by enhancing its market position suggests a proactive management approach. The company's operational efficiency is reflected in its financial metrics, with potential for further margin expansion. Investors should monitor macroeconomic factors and industry trends, such as infrastructure spending and regulatory changes, which could impact future growth. Overall, Bird Construction's disciplined execution and strategic positioning make it a compelling investment in the construction industry.

Pitch Summary:
We believe FTAI has multiple positive catalysts in the coming months, including PMA approval and continued progress on its Strategic Capital Initiative (SCI). Through its first SCI fund, FTAI raised $4 billion in debt and equity to acquire mid-life aircrafts, targeting a $30 billion market opportunity as lessors look to offload older assets in favor of newer models. FTAI has become a go-to buyer for these transactions, and under this structure, it also secures the associated engine maintenance contracts and is expected to contribute approximately $200 million in incremental annual aerospace EBITDA by 2026 once fully ramped. In January 2025, FTAI was targeted by a short report alleging that it is merely a leasing company disguising itself as an aftermarket business through questionable accounting practices. We strongly disagree. In our view, FTAI is a value-added aftermarket maintenance business that adheres to industry-standard leasing accounting. Notably, the report failed to mention the SCI, which we believe is a transformative driver of long-term value. Given the recent pullback in stock price, the overlooked value of SCI, and multiple upcoming catalysts, we believe FTAI is well-positioned for continued outperformance.

BSD Analysis:
Tourlite presents a strong rebuttal to short seller criticism while highlighting FTAI's Strategic Capital Initiative as a transformative growth driver. The manager emphasizes that FTAI has successfully raised $4 billion through its first SCI fund to target a $30 billion market opportunity in mid-life aircraft acquisitions, positioning the company as a preferred buyer for lessors rotating to newer assets. The SCI structure is particularly attractive as it secures both aircraft assets and associated engine maintenance contracts, with management projecting $200 million in incremental annual aerospace EBITDA by 2026. Tourlite directly addresses short seller allegations, defending FTAI as a legitimate aftermarket maintenance business using standard industry accounting practices. The manager argues that critics overlooked the SCI's transformative potential, viewing the recent stock pullback as creating an attractive entry point. Near-term catalysts include PMA approval and continued SCI progress, while the long-term thesis centers on FTAI's evolution from a traditional lessor to a value-added maintenance provider. The manager's conviction is evident in their detailed defense against short seller attacks and emphasis on the SCI's overlooked value creation potential.

Pitch Summary:
Despite the year-to-date share price performance, we are very optimistic as FIP should experience a positive inflection in fundamentals and cash flow over the next 12 months. As these catalysts play out, we believe there could be over 100% upside to FIP current share price of ~$5. FIP is approaching a fundamental inflection point. After years of groundwork, the company is poised to more than double earnings, with run-rate EBITDA expected to hit $300 million by year-end. There are several upcoming events such as new contracts and refinancing opportunities that could unlock meaningful value. In addition, FIP has multiple levers for growth including 1) datacenter development at Long Ridge this year, 2) incremental contracts at Jefferson, 3) a robust M&A pipeline at Transtar, and 4) further progress at Repauno with phase 3 permitting and phase 2 commencing operations in 2026.

BSD Analysis:
Tourlite presents an aggressive bull case for FTAI Infrastructure, projecting over 100% upside from the current $5 share price based on an anticipated fundamental inflection. The manager highlights a dramatic earnings transformation with run-rate EBITDA expected to more than double to $300 million by year-end, suggesting the company is emerging from a heavy investment phase. The investment thesis centers on multiple growth catalysts across FIP's diversified infrastructure portfolio, including datacenter development at Long Ridge, contract expansion at Jefferson, M&A opportunities at Transtar, and operational progress at Repauno. The manager emphasizes that years of groundwork are finally positioning the company for meaningful cash flow generation. New contracts and refinancing opportunities represent near-term value unlocking events, while the phased development at Repauno provides longer-term visibility with phase 2 operations beginning in 2026. This appears to be a classic infrastructure value play where patient capital investment is approaching the monetization phase. The manager's conviction is evident in their specific upside target and detailed catalyst timeline.

Pitch Summary:
Since our last letter, Sable, an exploration and production (E&P) company, has made substantial progress in restarting operations at the Santa Ynez Unit, an offshore asset acquired from Exxon that had been offline since a pipeline spill. Notably, the California Coastal Commission (CCC) has retreated from its previous attempts to exert what we believed were unjust authority over Sable, who is now pursuing $268 million in damages from the CCC for lost revenue. As of May 18th, Sable has completed all required repairs outlined in the Consent Decree governing the onshore pipeline restart. Seven of the eight pipeline segments have successfully passed hydrotesting, and production has resumed from six wells at the Santa Ynez Unit. Management expects oil sales to begin in July. Encouraged by strong early results, Sable has also revised its 2025 guidance, doubling projected daily production while simultaneously lowering lease operating expenses.

BSD Analysis:
Tourlite presents a compelling operational turnaround story for Sable Offshore, highlighting significant progress in restarting the Santa Ynez Unit operations after acquiring the asset from Exxon. The manager emphasizes key operational milestones including completion of required pipeline repairs, successful hydrotesting of seven out of eight pipeline segments, and resumption of production from six wells. The regulatory overhang appears to be clearing with the California Coastal Commission retreating from previous interference, while Sable pursues $268 million in damages for lost revenue. Management's revised 2025 guidance is particularly encouraging, with doubled projected daily production alongside reduced operating expenses, suggesting improving operational efficiency. The expected commencement of oil sales in July represents a near-term catalyst that could drive meaningful cash flow generation. This appears to be a classic asset restart play with multiple operational and financial catalysts converging. The manager's confidence is evident in their detailed tracking of operational progress and regulatory developments.

Pitch Summary:
Rusoro Mining is a litigation-driven special situation centered on its $1.7B ICSID arbitral award against Venezuela for expropriated gold mines, with recovery now linked to the Delaware court–supervised auction of CITGO Petroleum. The auction, already underway, will distribute sale proceeds from CITGO’s parent (PDVSA) to claimants including Rusoro, Crystallex, and others. Rusoro’s position—estimated eighth in line behind $3.7B of other awards and $1.95B PDVSA 2020 bond claims—implies meaningful recovery if CITGO sells for more than $7.4B. With CITGO’s equity likely valued between $11–13B, Rusoro could collect roughly $1.7B gross, translating to ~$1.1B net (~$1.70/share) after legal fees and contingencies, a >4× upside from current ~$0.44. The market’s skepticism stems from the complexity of inter-creditor waterfall mechanics, geopolitical risk, and opaque OFAC licensing, but bipartisan U.S. support for enforcement and the auction’s advanced stage mitigate timing risk. The case has transitioned from a dormant asset to a near-term payout event with a defined process and cash source. Effectively, RMLFF trades as a call option on the CITGO sale clearing above the claim threshold; even partial recovery would justify multiples of today’s price. Key risks include regulatory delays, pro-rata dilution among claimants, and additional legal costs, but these are outweighed by the asymmetry of the payout profile.

BSD Analysis:
Rusoro’s value lies entirely in its ICSID award enforcement against Venezuela, with the U.S. court–supervised CITGO sale providing a tangible monetization path. The market discounts complex claim hierarchy and political uncertainty, but the ongoing Delaware process makes this one of the few actionable, near-term sovereign recovery plays. Upside is substantial if CITGO clears above $7.4B; downside limited to legal expenses.

Pitch Summary:
KITS Eyecare is a rapidly growing, vertically integrated e-commerce eyewear retailer positioned to compound profitably as it captures share in the underpenetrated online vision-care market, driven by low-cost manufacturing, recurring revenue, and an experienced founder-led team.

BSD Analysis:
KITS Eyecare (KITS) is a vertically integrated online eyewear retailer operating primarily in the U.S. and Canada, offering prescription glasses, contact lenses, and sunglasses at disruptive price points. Founded by Roger Hardy, who previously built and sold Coastal Contacts to Essilor for $430M, KITS combines in-house optical lab automation with direct-to-consumer distribution to deliver high-quality, low-cost eyewear in 1–3 days. The company’s vertically integrated model drives industry-leading unit economics, allowing it to underprice competitors like Warby Parker and EssilorLuxottica while remaining profitable. KITS has grown revenue at 30%+ annually for ten straight quarters, with 70% of sales from repeat customers and gross margins approaching 40%. With scale efficiencies, operating leverage, and a strong management team owning ~70% of shares, KITS is on track to reach C$500M in sales and 10–15% EBITDA margins within five years. Trading at 2.0x sales and 26x FY25 EBITDA despite positive cash flow, KITS offers significant upside as online penetration in the $70B optical market rises.

Pitch Summary:
IHS is a leading emerging-market towerco (Africa/Brazil focus) that’s been crushed since its 2021 IPO by naira devaluation, governance disputes with key shareholders, and MTN renewal risk. Those headwinds have flipped: MTN Nigeria (≈46% of sales) renewed through 2032, board/ voting issues are resolved, and half the debt stack was refinanced to better match currency. Nigeria unified FX in 2023 and the naira has stabilized recently, which improves USD liquidity and planning. Strategically, management finished a 2024 review, sold subscale/ noncore assets in Kuwait (14× EBITDA) and Rwanda (8×), brought leverage into a 3–4× TNLR target (PF ≈3.1×), and flagged buybacks/ dividends for H2’25. The core businesses in Nigeria and Brazil still benefit from secular data growth, rising tenancy ratios, and outsourcing by MNOs. At ≈5× EBITDA and ~20% levered FCF yield, public valuation sits well below proven private marks on actual asset sales. Cash conversion is improving (capex down, ALFCF up), so capital returns can be meaningful against ~$4M/day trading liquidity. Concentration risk (MTN 63% rev in 2024 pre-renewal) and EM macro remain, but contract tenor, indexed pricing (FX resets), and a cleaned-up balance sheet mitigate the left tail. The setup is a classic “earn the multiple back”: even without full peer re-rate, de-lever + buybacks + modest tenancy growth can compound equity. If the market awards merely 6–7× on stabilized FX and capital returns, equity upside is material from a compressed base.

BSD Analysis:
Mispricing stems from 2023–24 Nigeria FX chaos, MTN renewal fears, and governance noise that obscured durable tower-economics. Now, with MTN locked into 2032, FX indexing/ resets functioning, disposals done at 8–14×, and leverage at ~3.1× TNLR, the cash engine can pivot to buybacks/dividends in H2’25. Core edge is local scale and contracts in markets where data growth and outsourcing are early. Key risks are renewed FX volatility, customer concentration, and policy surprises; mitigants are USD-indexed pricing, multi-year tenors, and a clearer capital allocation framework.

Pitch Summary:
Howden is a vertically integrated, trade-only kitchen and joinery supplier whose dense, always-in-stock depot network gives it a cost, service, and availability moat that retail-oriented rivals can’t match. Scale plus in-house manufacturing (~40%+ vertically integrated, moving toward 50%) support >60% gross margins and ~20% EBIT margins at mature depots while sharing economics with small-builder customers (credit terms, fast delivery, confidential pricing). Competitors continue to retrench (Homebase, B&Q install pivot, Nobia/Magnet closures, Benchmarx subscale), so trade channel share is rising and Howden has taken share through recessions. UK kitchen volumes sit at GFC-like trough levels (~1.1–1.2m installs vs ~1.5–1.6m normalized), setting up multi-year volume recovery; each +1% volume adds ~40 bps to EBIT/PBT margin. New XDC hubs and re-racking raise SKU breadth without clogging depots and open near-adjacencies (higher-end kitchens, bedrooms) while the French/Ireland runway (78 depots to a ~300 longer-term opportunity) offers optional upside. Investment phase is peaking: SAP complete, supply chain/manufacturing build-out largely done, >60% of estate reformatted; capex should drift from ~5% sales toward ~3–4% (or ~2% maintenance), letting FCFE convert. Gross margin can sit in the 61–63% “sweet spot” as mix and scale offset only modest price increases, and depot maturation adds 1–1.5% to LFLs annually. Balance sheet is net cash, cash tax runs below P&L tax (patent box), and management historically returns surplus cash (buybacks/specials). On cash, the stock screens better than P/E: ~7–8% FCFE yield next 12 months, ~9% on maintenance capex assumptions, rising toward low-double digits as volumes normalize. Shares trade ~13–14x TEV/EBIT ’26 and ~17–18x FCFE TTM—reasonable for a category killer compounding share, margins, and ROIC with mid-teens total return potential (plus upside from a US rate-led housing-transactions recovery). Risks are UK macro/housing turnover, execution in bedrooms/France, and depot density saturation, but mid-cycle utilization, benign competition, and peaking investment skew the setup favorably now.

BSD Analysis:
Why now: UK install volumes are at cyclical troughs while the competitive field has weakened, setting up positive operating leverage as activity normalizes. The heavy lift in systems, manufacturing, and distribution is largely complete, so capex and cost growth should moderate and depreciation drag roll off, letting FCFE convert. XDCs and re-racking expand range without depot bloat and enable credible near-adjacencies (bedrooms, higher-end), while depot maturation adds steady LFL tailwinds. Mature-depot economics (~20% EBIT) and 61–63% GM remain intact, supported by vertical integration and scale purchasing. Net cash and below-P&L cash taxes support buybacks/specials, and management’s disciplined rollout (toward ~1,000 UK depots) keeps returns high. With mid-cycle dollar utilization and sub-peer EV/S, the risk/reward looks favorable even if France remains a slow burner.

Pitch Summary:
Cronos Group (CRON) is a rare net-net in the cannabis space, trading near its ~$1.2B cash balance with no debt and an enterprise value below zero, despite improving profitability and a $50M share repurchase authorization. The company has narrowed losses for six straight quarters, achieving both positive net income and EBITDA in 1Q25, supported by supply normalization in Canada and high-margin European exports. Cronos’s balance sheet remains among the strongest in the industry, with net cash exceeding its entire market cap (~C$1.1B vs. C$1.2B cash). Structural reforms and tightening supply have shifted the Canadian market from chronic oversupply to more balanced conditions, while exports to Germany and other European countries now drive margin expansion—international margins run roughly 40% vs. 25% in Canada. Management cites supply constraints in premium strains, with new capacity coming online in 2H25 to meet growing European demand. The recently announced buyback, amounting to ~5% of shares outstanding (or ~8.5% ex-Altria’s 41% stake), signals confidence and adds tangible downside support. Longer term, Cronos remains an asymmetric option on regulatory reform: U.S. descheduling or Canadian excise tax relief could trigger large re-ratings across the sector. Excise taxes of up to 30% currently weigh heavily, and a flat 10% structure would meaningfully expand margins. Altria’s 41% ownership also gives Cronos a credible path to U.S. market entry upon legalization. Risks include possible Israeli import tariffs (affecting ~30% of revenue), potential European anti-dumping measures, and commodity pricing pressure in flower, but downside is underpinned by the company’s net-cash position. With peer EV/S multiples around 2× sales and Cronos generating positive EBITDA, even modest multiple normalization implies ~$4/share (~40% upside), while legalization could drive $6/share (~110% upside).

BSD Analysis:
Cronos’s unique mix of balance-sheet strength, positive earnings inflection, and new buyback authorization create a compelling floor in an otherwise distressed sector. Investors gain exposure to a cleaned-up, cash-backed business with improving fundamentals and asymmetric upside to cannabis reform. Market neglect and policy uncertainty obscure the turnaround, but the setup offers limited downside and multiple re-rating paths.

Pitch Summary:
Ashtead (Sunbelt in the U.S.) is a scale equipment-rental leader that the market still prices like a cyclical distributor despite multi-year structural tailwinds. Over 85% of value comes from Sunbelt US/Canada, where Ashtead and URI are the only true national players, yet together they control just ~26% of a still-fragmented market. Scale drives persistent cost and revenue advantages: 15–20% OEM purchase discounts, in-house disposal without auction fees, higher dollar utilization (~57% vs ~40% for mid-caps), and lower staff/SG&A as a percent of sales. Technology is widening the moat (ERP, telematics, dispatch route mapping, and dynamic pricing down to the ZIP code), improving load factors and price realization. Industry structure supports pricing because most competitors are sub-scale and end customers are fragmented, time-sensitive, and price-inelastic for a small line item in large projects. Secular growth should be durable: rental penetration in North America (~55%) has a clear path toward 70–75% over a decade, aided by “specialty” categories (power, HVAC, restoration, film/events) and sustainability/asset-light trends. Management’s growth algorithm—organic 6–9% plus heavy reinvestment into fleet, greenfields, and tuck-ins—can compound revenue ~14% and EBITDA ~15% annually, consistent with long-term history. Dollar utilization and revenue/PP&E sit near long-run averages, suggesting mid-cycle rather than peak conditions. Shares trade ~6–6.5× forward EBITDA (below 10-yr average ~7×) and at a discount to URI despite higher returns on capital and a more balanced (less levered, less mega-M&A-dependent) capital allocation. A prospective U.S. primary listing could narrow the gap, while a 2.5% dividend boosts total return into the high-teens if execution continues. The risk is macro/cycle, but dynamic pricing and scale should cushion a downturn versus GFC-era behavior.

BSD Analysis:
Ashtead combines structural share gain, rising rental penetration, and scale-driven unit economics to deliver double-digit organic growth with operating leverage. The setup is mispriced because investors anchor to “rental = cyclical” and the UK listing masks a predominantly U.S. franchise. Mid-cycle utilization, sub-historical EV/EBITDA, and a measured balance sheet reduce left-tail risk; tech-enabled pricing/telematics and specialty mix expand right-tail. U.S. listing and continued tuck-ins/fleet growth are practical near-term unlocks for multiple convergence with URI.

Pitch Summary:
The author argues that Webjet Group ($WJL.AX) is at the center of an emerging takeover contest following a rejected A$0.80/share bid from BGH Capital. Despite the rejection, the stock trades above the offer price, reflecting expectations of a higher bid, especially as BGH accumulated much of its ~11% stake around A$0.80. Competing interest has surfaced from Helloworld Travel, which is believed to have built a ~10% position after its own merger proposal was rebuffed, with recent buying around A$0.85/share. Valuation looks undemanding at ~5.7× EBITDA and ~8× EBITDA less capex, below both global OTA peers and WJL’s own spin-off valuation above A$1/share. Solid FY25 results, with EBITDA meeting guidance despite macro pressure, add fundamental support. The presence of credible financial and strategic bidders underpins the view that upside of at least ~20% is achievable.

BSD Analysis:
The online travel agency industry favors scale, supplier relationships, and technology leverage, but subscale regional players can still be strategically valuable to both private equity and industry consolidators. Webjet’s competitive position in Australia is defensible, with established brands and margin improvement potential even in a softer demand environment. The industry structure supports consolidation, particularly as post-pandemic normalization pressures smaller platforms to seek partners or sponsors. The involvement of both a sophisticated PE buyer and an industry peer materially increases deal probability and downside protection. Key risks are bid fatigue and regulatory or board resistance that could stall momentum. However, stake-building at or above current prices signals conviction from informed buyers. Valuation remains below transaction and peer benchmarks, suggesting the market is still discounting a no-deal outcome. If a higher offer or competitive process emerges, WJL could re-rate quickly toward its prior spin-off multiple.

Actual Post Content:
Interesting bidding war developing over one of the leading OTA players in Australia, $WJL.AX. Online travel booking platform Webjet Group has received an offer from private equity firm BGH Capital at A$0.80 per share, which was subsequently rejected by the board. However, the stock continues to trade above A$0.80, likely in anticipation of an increased bid. BGH has built a substantial portion of its current 11%+ stake around the A$0.80/share level. Meanwhile, as the BGH saga was unfolding, another Australian Stock Exchange-listed travel company, Helloworld Travel, began acquiring shares in WJL and was rumored to have pitched a merger proposal to WJL’s board. According to the same source, the proposal was also rejected. Following this, Helloworld moved into the market and increased its stake. It is now believed to hold around 10% of the company (only 5% disclosed thus far), with the second half of its position acquired at A$0.85 per share, essentially in line with current prices. From a valuation perspective, WJL looks cheap, trading at just 5.7x EBITDA and 8x EBITDA minus capex, with normalized capex likely to be lower. Most international peers trade at significantly higher multiples, though comparisons are somewhat limited due to scale differences between local and global OTA platforms. It’s worth noting that WJL debuted on the Australian Stock Exchange as a spin-off at the end of last year, priced above A$1/share and valued at a 7.5x EBITDA multiple, so there is clearly room for an increased offer here. What makes this situation particularly compelling is the presence of highly credible and experienced bidders with deep travel industry expertise. BGH Capital is a respected Australian private equity fund with A$6bn in AUM and a track record in the travel sector, including its prior investment in TripADeal, which was sold to Qantas last year. Alongside BGH, Garry Weiss is also involved in the bid, he’s a well-known Australian investor who has chaired numerous prominent public companies. And now we also have an industry peer acquiring shares in the company shortly after BGH’s interest became public. At post spin-off multiple, there is at least 20% upside from current levels. Finally, the company reported its fiscal 2025 results yesterday, which were solid. EBITDA met management guidance on improved margins, despite macro headwinds weighing on revenue. Watching this closely.

URL: https://x.com/InvestSpecial/status/1925485516159431127

Pitch Summary:
The author argues that Water Intelligence is outperforming peers during a challenging macro environment by scaling its leak detection and preventive maintenance platform across the U.S. Its latest trading update shows steady revenue growth and margin expansion driven by economies of scale. New initiatives with StreamLabs/Chubb and preventive maintenance appear to be accelerating sales. Broker forecasts indicate attractive valuation multiples given recurring revenues. Overall the pitch frames WATR as a resilient, underpriced operator with structural tailwinds from aging infrastructure, climate-driven pressures, and channel expansion.

BSD Analysis:
Water Intelligence operates in a niche within infrastructure services that benefits from non-discretionary demand, insurer alignment, and regulatory pressure to reduce water loss. Its franchise-heavy model supports margin scalability, and partnerships with insurers enhance distribution. Preventive maintenance aligns with long-term trends in utilities and commercial property management. Risks include franchise execution consistency and competitive bidding dynamics, but if execution remains strong WATR can continue compounding earnings through operational leverage and broader adoption of tech-enabled leak detection.

Actual Post Content:
#WATR Often during challenging economic periods, the best companies outperform their rivals by executing well and investing in the long term. This is exactly the case for @WaterIntelPLC – a ‘one stop shop’ for all things leak detection, repair & preventative maintenance (approx. 2/3rds franchised). Indeed it is already the largest operator in the US, and today released an in line April YTD’25 trading update – posting turnover and adjusted EBITDA up 8% and 13% respectively to $29.1m & $5.2m. Representing improved EBITDA margins of 17.7% (17.0% LY) due to economies of scale - & a closing net debt to EBITDA ratio of 1.5x, which is comfortable for a high repeat revenue business. The impressive growth was not only driven by its best-in-class solutions that save water, minimize sewage spills, cut the cost of insurance bills and reduce regulatory fines. But also thanks to its recent StreamLabs Water partnership (part of Chubb Insurance) and the launch of a new seamless Preventive Maintenance service, which proactively manages and stops water leaks for residential, commercial and municipal customers, importantly before they occur. In fact both of these important initiatives, appear to be already coming through in the numbers - where April saw an encouraging 20% jump in sales compared to 4% in Q1'25. Hopefully this trend will continue, underpinned too by the secular tailwinds of global warming, aging infrastructure & climate change (eg water conservation & stormwater damage), on top of #WATR's broadening channel distribution and sharp execution. In terms of the numbers, house broker @DowgateCapital is forecasting FY25 turnover, EBITDA, PBT & EPS to come in at $97.0m, $17.5m, $11.2m and 44.3 cents. In turn putting the stock on modest EV/EBITDA, PE and PEG ratios of 6.0x, 10.5x and 0.5x – which frankly appears far too cheap for an economically resilient, growth platform. In comparison, @DowgateCapital have a 850p/share target price. Executive Chairman, Patrick DeSouza commenting: 'We have launched a defining partnership with Chubb/StreamLabs and now have the capability to execute a true integrated platform with operations across the US and overseas. Preventive Maintenance, rather than Reactive Mitigation, is where the industry is headed, both to conserve water and limit the damage from water leakage'. '[Additionally] we remain focused on continuing to grow revenue and profits, while retaining a strong balance sheet with which to execute our competitive strategy.' Finally the Board is also considering a separate dual listing in the US, and from this month American investors can now purchase shares via Interactive brokers. Disclosure: I own shares in @WaterIntelPLC , who is also a @VOXmarkets client.

URL: https://x.com/CapitalPmh/status/1925452690940686846

Pitch Summary:
The Fannie Mae preferred shares (FNMAS) present a compelling, derisked opportunity ahead of the GSE’s long-awaited release from 17 years of government conservatorship, with the prospect of dividend reinstatement and nearly 100% upside to par value.

BSD Analysis:
Fannie Mae preferreds (FNMAS) offer an attractive risk/reward profile as both political and financial conditions align for the GSE’s exit from conservatorship. After years of capital retention, Fannie’s net worth has grown from $13.5B in 2020 to $98B in 2025, approaching the level needed for release. Newly appointed FHFA Director Bill Pulte—a private-sector housing veteran—and Treasury Secretary Bessent are ideologically aligned with President Trump’s goal of reprivatizing the economy and reducing the federal balance sheet. Trump recently confirmed his intent to bring the GSEs public, signaling a 2026 IPO and the end of the net worth sweep. Treasury’s likely forgiveness or conversion of its senior preferred stake would allow Fannie to resume dividends on its junior preferreds, including FNMAS, which pays an 8.25% coupon (LIBOR + 423bps float). These shares, trading at 55% of par, could re-rate toward $27 upon reinstatement of dividends or redemption, implying nearly 100% upside. With rising profitability, strong capital, and aligned political incentives, FNMAS provides a liquid, asymmetric play on the GSE’s release—offering greater downside protection than the common equity while maintaining meaningful upside potential.

Pitch Summary:
Electro-Sensors is an illiquid, family-controlled nanocap industrial sensor maker trading just above net cash and below liquidation value, offering asymmetric optionality on a sale or strategic event. The company manufactures machine monitoring and hazard detection systems (speed, temperature, and position sensors) used across grain, feed, ethanol, and manufacturing plants. Revenue is stable (+3% CAGR since 2016, -8% during COVID), but profitability minimal (~break-even, $1.5M cumulative op income over eight years). The appeal lies in the balance sheet and control dynamics: ELSE has ~$10M net cash and ~$2.7M net working capital versus a ~$13M market cap, plus a fully owned HQ building appraised at ~$2.85M. The Peterson siblings—five heirs in their 60s holding a combined 52% stake—now control the company, each with ~$1.3M in stock (down from $2.2M when inherited in 2021). They are retired, have no meaningful comp, and have already shown willingness to monetize: in 2022 they agreed to a reverse merger that would’ve paid shareholders an $18M cash dividend (~$4.83/share) before the buyer’s PIPE fell through. Following termination, the board formed a special committee to pursue “strategic alternatives,” still active per filings. The likeliest outcome is a sale to a private industrial automation roll-up (Flow Control, Dwyer, INTT, etc.) or competitor (AGI, Siemens, 4B, Maxi-Tronic). Else’s stable niche, customer stickiness, and non-cyclical demand suggest intrinsic operating value for a buyer—post-acquisition synergies (price normalization + $700k in cost cuts) could yield $1.7M run-rate EBIT worth $8–13M (5–8×), implying 50–100% upside from today’s levels before adding excess cash. Timing is the only uncertainty, but with aging family owners and a dormant stock, a liquidity event within 12–36 months appears probable.

BSD Analysis:
A microcap liquidation-plus-catalyst story: ELSE trades at ~0.3× book and <1× tangible net asset value, supported by $10M cash, real estate, and a recurring industrial product line. The five Peterson siblings, newly in control, are financially aligned and incentivized to sell. The failed 2022 merger proves board willingness to monetize. A sale to a strategic consolidator could yield 15%+ EBIT margins and 2–3× current equity value. Downside is cushioned by net cash and owned property; risk lies mainly in timing and liquidity.

Pitch Summary:
Cytek is a cash-rich, IP-heavy flow cytometry vendor whose shares imply an enterprise value under $50M despite ~$200M 2025E revenue and positive adj. EBITDA. The company leads “full spectrum” flow with Aurora analyzers/sorters that let labs read more markers per sample, replacing multiple legacy boxes at lower total cost. Hardware is ~70% of sales, but a 30% and rising mix of reagents, service, and software adds recurring stability as the installed base matures. Gross margins sit in the high-50s, supported by proprietary laser modules and in-house manufacturing, and the firm remains FCF positive through the downturn. Channel work and user feedback indicate steady share gains versus BD/Sony/Agilent on ease of use, panel flexibility, and price/performance. A clinical platform and an imaging-integrated high-end system are in the pipeline, expanding TAM and pushing up mix/ASPs. Balance sheet is the kicker: ~$265M net cash (~$2.08/sh) plus net working capital of ~$0.37/sh against a ~$2.45 stock makes the operating business essentially free. Management has been repurchasing shares and signals discipline on M&A (high-GM, accretive in year one). Sector sentiment is washed out (NIH pressure, startup closures), but Cytek differs from many small-cap tools peers by being profitable, cash-rich, and strategically valuable. On author estimates, adj. EBITDA could rise from ~$10M in 2025 to ~$24M/$36M/$44M by 2026/27/28, making today’s EV/EBITDA multiple de minimis and giving ample room for multiple normalization. Strategic (tools/diagnostics) or financial buyers could unlock reagent cross-sell, supply-chain synergies, and cost takeout at a cycle low.

BSD Analysis:
The market is extrapolating weak tools sentiment onto a business with leading tech, high gross margins, and a fortress balance sheet that covers ~70%+ of market cap in cash alone. With EV effectively near zero, investors get a profitable spectrum-flow franchise, growing recurring revenue, and product catalysts for free. Risks (funding cycle, competition, capital allocation) are real, but buybacks, disciplined M&A criteria, and user adoption trends mitigate them. If sentiment merely normalizes, modest growth plus a return to mid-teens EV/EBITDA on 2026–27e yields attractive upside with limited downside.

Pitch Summary:
Celsius stumbled in 2024 as Pepsi distribution comps, inventory swings, and promo intensity dented growth optics—raising durability doubts. The February 2025 acquisition of Alani Nu is a step-change: it removes the fastest-growing competitor, adds a complementary, female-skewed brand, and came at ≈3× 2024 sales/ ~12× post-synergy EBITDA funded mostly with cash/ modest debt. Pro forma market share exceeds 15%, and Alani’s retail growth (+88% 1Q25) plus Pepsi’s system should extend category outperformance. Management expects ≈$50M cost synergies and sees Alani a couple of years behind CELH on margin expansion, offering operating leverage as it scales. A new Pepsi veteran COO de-risks integration and deepens bench strength. Distribution headwinds should ease as sell-in/ sell-out normalize in 2H’25, while c-store cooler expansion and international launches (Canada/UK/EU/AU/NZ) provide runway—international is <10% of CELH vs ~40% at Monster. On conservative framing, EBITDA can climb from ~$343M PF (’24) to ~$600M+ by 2027 with only mid-single-digit CELH growth, decelerating but strong Alani growth, and modest synergy realization. That would place CELH near ~3× sales/ ~15× EBITDA by 2027—well under MONSTER’s long-term multiples despite similar structural tailwinds. Optionality remains for a deeper Pepsi tie-up given the long-dated distribution pact and PEP’s equity. Risks: integration/ brand execution, sustained promo pressure, and category decel; still, the deal improves mix, breadth, and margin trajectory.

BSD Analysis:
The edge is portfolio breadth + Pepsi distribution: Alani adds a high-velocity brand in a distinct demo, lowering competitive pressure and raising combined shelf power. Mispricing stems from 2024’s sell-in/ sell-out gap and fears of slowing CELH growth; Alani’s growth and synergies cushion while international and c-store penetration extend runway. Watch integration pace, promo intensity, and international traction; if EBITDA approaches ~$600M+ by 2027, even a discounted multiple implies attractive upside from current TEV.

Pitch Summary:
Changed "Principal Executive Office" address to an office on Wall Street in SEC filings to get into the Russell 1000 index.

BSD Analysis:
Freedom Holding faces scrutiny for opaque governance, Kazakhstan/Russia exposure, and regulatory investigations. The short thesis argues reported profitability is overstated due to related-party activity and questionable cross-border structures. Risks include sanctions, compliance enforcement, and capital flight, leaving downside if regulators tighten.

Pitch Summary:
The business model is collapsing under regulatory pressure; outdated technology; the top customer is leaving; main partner bank is under FBI investigation for anti-money laundering failures.

BSD Analysis:
Marqeta’s growth in card issuing faces intense competition from Stripe, Adyen, and legacy processors. Bears emphasize customer concentration (esp. Block), pricing pressure, and path to profitability. Rising interest rates reduce interchange economics, while dependence on BNPL fintechs raises credit risk exposure indirectly.